Vanda Pharmaceuticals Inc. announced on Friday that the U.S. Food and Drug Administration has accepted the first drug Hetlioz (tasimelteon) 20mg capsules, a melatonin receptor agonist to treat a sleep condition that affects blind individuals. Vanda anticipates making Hetlioz commercially available in the second quarter of 2014. The sleep disorder root to the inability of a completely blind … [Read more...]
You are here: Home / Archives for non 24 Hour Sleep-Wake Disorder